The CAR macrophage cells, a novel generation of chimeric antigen-based approach against solid tumors

Today, adoptive cell therapy has many successes in cancer therapy, and this subject is brilliant in using chimeric antigen receptor T cells. The CAR T cell therapy, with its FDA-approved drugs, could treat several types of hematological malignancies and thus be very attractive for treating solid can...

Descripción completa

Detalles Bibliográficos
Autores principales: Hadiloo, Kaveh, Taremi, Siavash, Heidari, Mahmood, Esmaeilzadeh, Abdolreza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685521/
https://www.ncbi.nlm.nih.gov/pubmed/38017494
http://dx.doi.org/10.1186/s40364-023-00537-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685521/
https://www.ncbi.nlm.nih.gov/pubmed/38017494
http://dx.doi.org/10.1186/s40364-023-00537-x

Ejemplares similares